News Releases | Maravai LifeSciences Holdings LLC

Date	Title and Summary	Additional Formats
September 10, 2021	Maravai LifeSciences Announces Pricing of Secondary Offering of Class A Common Stock by Selling Stockholders SAN DIEGO, Calif., Sept. 10, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI) , a global provider of life science reagents and services to researchers and biotech innovators, today announced the pricing of a public offering of 20,000,000 shares of Maravai’s
September 7, 2021	Maravai LifeSciences Announces Launch of Proposed Secondary Offering of Class A Common Stock by Selling Stockholders SAN DIEGO, Calif., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI) , a global provider of life science reagents and services to researchers and biotech innovators, today announced the commencement of a public offering of its Class A common stock by
September 7, 2021	Maravai LifeSciences Announces September 2021 Investor Conference Schedule SAN DIEGO, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following virtual investor conferences during the month of September.
August 10, 2021	Maravai Lifesciences Reports Second Quarter Financial Results and Updates 2021 Financial Guidance SAN DIEGO, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the second quarter ended June 30, 2021, together with other
August 2, 2021	TriLink BioTechnologies® Extends Global Support of Covid-19 Vaccine Development into APAC Region with the Chula Vaccine Research Center (Chula VRC), Bangkok TriLink enables Chula VRC to take its Covid-19 vaccine into a First in Human (FIH) phase 1 clinical trial in Thailand with mRNA manufacturing process development and its proprietary mRNA capping technology, ushering a much-needed vaccine into economically developing countries SAN DIEGO, Aug.
July 20, 2021	Maravai LifeSciences To Host Earnings Conference Call on Tuesday, August 10, 2021 SAN DIEGO, July 20, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its second quarter 2021 financial and operating results after the market closes on
May 26, 2021	Maravai LifeSciences Announces June 2021 Investor Conference Schedule SAN DIEGO, May 26, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following virtual investor conferences during the month of June.
May 10, 2021	Maravai Lifesciences Reports First Quarter Financial Results and Updates 2021 Financial Guidance SAN DIEGO, May 10, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai)(NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the first quarter ended March 31, 2021.
May 5, 2021	Maravai LifeSciences Announces Investor Conference Schedule for the Month of May 2021 SAN DIEGO, May 05, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following virtual investor conferences during the month of May.
April 13, 2021	Maravai LifeSciences To Host Earnings Conference Call on Monday, May 10, 2021 SAN DIEGO, April 13, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its first quarter 2021 financial and operating results after the market closes on